血栓抽吸后应用替罗非班对心肌再灌注的影响(3)
 |
| 第1页 |
参见附件。
[7] Iversen A， Abildgaard U，Alloe A，et al. Intracoronary Compared to Intravenous Bolus Abciximab during Primary Percutaneous Coronary Intervention in ST-segment Elevation Myocardial Infarction (STEMI) Patients Reduces 30-day Mortality and Target Vessel Revascularization： A Randomized Trial[J]. J Interv Cardiol，2011，24(2)：105-111.
[8] Eitel I，Friedenberger J，Fuernau G，et al. Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention：6-month effects on infarct size and left ventricular function：The randomised Leipzig Immediate PercutaneouS Coronary Intervention Abciximab i.v. versus i.c. in ST-Elevation Myocardial Infarction Trial(LIPSIAbciximab-STEMI)[J]. Clin Res Cardiol，2011，100(5)：425-432.
[9] Li SY，Yan HB，Wang J，et al. Efficiency and safety of thrombus aspiration plus intra-infarct-related artery administration of tirofiban during primary angioplasty[J]. Chin J Cardiol，2010，38(10)：880-885.
(收稿日期：2011-06-03)
您现在查看是摘要介绍页，详见PDF附件(2974kb)。